The Hepatitis B vaccine HB-Vax demonstrated high efficacy, with 94.7% seroconversion in healthy individuals. Immune response varied by age and health status, with poorer outcomes in dialysis patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: